Cerebrovascular Diseases

Papers
(The H4-Index of Cerebrovascular Diseases is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Factors Associated with Discharge against Medical Advice among Acute Stroke Patients: Analysis of the Nationwide Emergency Department Sample33
Intensive Blood Pressure Lowering and Renal Function in Ischemic Stroke Patients: Secondary Analysis of the ENCHANTED Trial25
Impact of RNF213 c.14576G>A Variant on the Development of Direct and Indirect Revascularization in Pediatric Moyamoya Disease22
Retraction Statement21
Normobaric Hyperoxia Combined with Endovascular Treatment in Patients with Acute Ischemic Stroke (OPENS-2) Trial: Protocol for a Prospective, Multicenter, Randomized Controlled Study20
Circadian Rhythm Disturbance in Acute Ischemic Stroke Patients and Its Effect on Prognosis17
Reply to the Letter to the Editor: Intraoperative Cortical Indocyanine Green Extravasation as a Predictor of Cerebral Hyperperfusion following Direct Revascularization for Moyamoya Disease: Impact of 17
Rising Trends in Cerebrovascular Disease and Substance Use-Related Mortality in the USA from 1999 to 2020: A Retrospective Analysis Using CDC WONDER17
Asia Pacific Stroke Conference 2024 Combined Australian and New Zealand Stroke Organisation Conference16
9th World Intracranial Hemorrhage Conference (WICH) 2025, Wesley Conference Centre, Sydney, Australia, March 28-29, 2025: Abstracts15
Variation in Ischemic Stroke Payments in the USA: A Medicare Beneficiary Study14
Development and Validation of a Prediction Model for 30-Day Mortality and Functional Outcome in Patients with Primary Brainstem Hemorrhage14
Sex-Based Differences in the Outcomes of Intracerebral Haemorrhage: A Systematic Review and Meta-Analysis14
Parental Influence on Intracerebral Hemorrhage Onset in Hereditary Dutch-Type Cerebral Amyloid Angiopathy14
Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes with Alteplase at 0.6 mg/kg in Clinical Practice: THAWS2 Study14
0.75021910667419